
Alert: Rating Upgrade (10/17/25)-Teva Pharmaceutical Industries L (NYSE: TEVA).
Stock Rating Upgrade The Value Trend Rating for Teva Pharmaceutical Industries L (NYSE: TEVA) improved of late from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]